Technology to accurately assess brain health
Backed by over 30 years of scientific discovery and validation, Cambridge Cognition offers the end-to-end platform for CNS clinical trials. Our technologies are reliable in-clinic or at home for an improved patient experience and accelerated drug development.
Trusted by the world’s top researchers
Leading pharmaceutical organisations, research institutions and healthcare professionals around the world rely on us to consistently deliver accurate and highly sensitive assessments that are capable of detecting even subtle cognitive changes.
30+ years' experience in assessment technology
Delivering leading digital cognitive assessments, decentralised clinical trials platform and healthcare tools, our team of neuroscientists and data specialists, consultants and project managers will help you design and deliver a study that fulfils your research goals and assess patients accurately.
assessed on our
digital health tools
papers & articles
The world’s top pharmaceutical organisations, research institutions and healthcare professionals trust our technologies to consistently deliver highly sensitive and accurate results.
Touchscreen cognitive assessments
Electronic questionnaires & scales
Rapid, cost-effective scale review to ensure high-quality data and your trial’s best chance at success
Since CANTAB® was first developed, our digital cognitive assessments have been validated in over 3,000 publications and more than 250 indications. Take a closer look at some of the therapeutic areas that have benefitted from our expertise.
Latest research news
Our neuroscience specialists and product experts are on hand to answer your questions.